About 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one
4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one (PubChem CID 71183179) has the molecular formula C21H18F3N3O3
and a molecular weight of 417.39 g/mol. Its IUPAC name is 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one.
Molecular Properties
| Compound Name | 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one |
| PubChem CID | 71183179 |
| Molecular Formula | C21H18F3N3O3 |
| Molecular Weight | 417.39 g/mol |
| Exact Mass | 417.13 |
| IUPAC Name | 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one |
| SMILES | Cn1ccnc1CN1CCOc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2C1=O |
| InChI | InChI=1S/C21H18F3N3O3/c1-26-9-8-25-19(26)13-27-10-11-29-18-7-4-15(12-17(18)20(27)28)14-2-5-16(6-3-14)30-21(22,23)24/h2-9,12H,10-11,13H2,1H3 |
| InChIKey | FOORLPBGPRHTSK-UHFFFAOYSA-N |
| XLogP | 4.02 |
| TPSA | 56.59 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 417.39 |
| LogP ≤ 5 | 4.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Analyze 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The IUPAC name of 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one (CID 71183179) is 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one.
What is the SMILES notation for 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The canonical SMILES for 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one is Cn1ccnc1CN1CCOc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2C1=O.
What is the InChIKey of 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The InChIKey is FOORLPBGPRHTSK-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H18F3N3O3/c1-26-9-8-25-19(26)13-27-10-11-29-18-7-4-15(12-17(18)20(27)28)14-2-5-16(6-3-14)30-21(22,23)24/h2-9,12H,10-11,13H2,1H3.
What are the key properties of 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one?
4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one has a molecular weight of 417.39 g/mol, XLogP of 4.02, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(1-methylimidazol-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one is sourced from PubChem (CID 71183179), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).